| Literature DB >> 35304431 |
Monika Sohal1, Pavneet Singh1, Bhupinder Singh Dhillon1, Harbir Singh Gill2,3.
Abstract
OBJECTIVES: Journaling is a common non-pharmacological tool in the management of mental illness, however, no clear evidence-based guideline exists informing primary care providers on its use. We seek here to present this synthesis that may begin to inform future research and eventual evidence-based guideline development.Entities:
Keywords: family medicine; health knowledge, attitudes, practice; mental health; physicians, primary care
Mesh:
Year: 2022 PMID: 35304431 PMCID: PMC8935176 DOI: 10.1136/fmch-2021-001154
Source DB: PubMed Journal: Fam Med Community Health ISSN: 2305-6983
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 flow diagram.
Inclusion and exclusion criteria used in primary and secondary screenings
| Inclusion criteria | Exclusion criteria |
| Peer reviewed | Studies which examined the effect of multiple types of journaling |
| Randomised control trials | Studies with insufficient or missing data which was required to perform a meta-analysis |
| Studied the impact of a journaling intervention on mental illness | Studies which examined the effects of a journaling intervention on well-being only |
Intervention parameters including journaling duration, journal analysis and/or collection and preparatory session administration preintervention
| Study | Journaling session duration | No of journaling sessions | Journals collected and/or analysed | Preparatory session* |
| Alparone | 20 | 3 | Yes | No |
| Bernard | 15 | 3 | Yes | No |
| Dennick | 20 | 3 | Yes | No |
| Di Blasio | Unspecified | 2 | No | No |
| Ducasse | Unspecified | 7 | No | No |
| Graf | 20 | 2 | No | No |
| Horsch | 15 | 3 | Yes | No |
| Jensen-Johansen | 20 | 3 | No | No |
| Barton & Jackson (2008) | 20 | 3 | Yes | No |
| Koopman | 20 | 4 | No | No |
| Barry and Singer (2001) | 20 | 4 | Yes | No |
| Lovell | 20 | 3 | Yes | No |
| Suhr, Risch and Wilz (2017) | Unspecified | 3 | No | No |
| Martino | Unspecified | 2 | No | No |
| Meshberg-Cohen | 20 | 4 | Yes | No |
| Possemato | 15 | 3 | Yes | No |
| Rabiepoor | 15 | 21 | No | No |
| Rawlings | 20 | 4 | Yes | No |
| Schache | Unspecified | 32 | No | No |
| Wong and Mak (2016) | 20 | 3 | Yes | No |
*A preparatory session refers to an educational session given to participants preintervention which outlines the mechanisms and theories underlying the efficacy of journaling as well as how to journal in the most effective manner.
Results of meta-regression without subgroups
| Study arm | Intervention arm | Control arm | ||||
| Variable | Regression coefficient | P value | Regression coefficient | P value | ||
| Sample size | 0.023 | 0.445 | −0.025 | 0.247 | ||
| Type of journaling | −0.043 | 0.176 | −0.036 | 0.124 | ||
| Study duration | −0.052 | 0.183 | −0.043 | 0.147 | ||
| Journal analysis | −0.064 | 0.021* | −0.026 | 0.254 | ||
| Sex | 0.052 | 0.063 | 0.030 | 0.158 | ||
| Age | 0.019 | 0.503 | −0.034 | 0.111 | ||
| Region-Europe | −0.097 | 0.217 | 0.502† | −0.023 | 0.714 | 0.971† |
| Region-North America | −0.122 | 0.150 | −0.022 | 0.750 | ||
| Region-Australia | −0.060 | 0.596 | −0.042 | 0.635 | ||
| Depression‡ | 0.060 | 0.122 | 0.266 | 0.006 | 0.838 | 0.763 |
| PTSD‡ | 0.030 | 0.459 | 0.022 | 0.51 | ||
*Sample size <30 or>30.
†When regions analysed in aggregate.
‡Depression and PTSD regression analyses were calculated using anxiety as the reference category.
PTSD, post-traumatic stress disorder.
Figure 2Standardised forest plot for control and intervention groups.
Figure 3Histogram of Cohen’s d effect size of journaling efficacy. n indicates the numbers of participants within each Cohen’s effect size classification.